On the other hand, hyperkinesis in dark phase and anxiety, clearly reported for both models (Figure 4), could be connected with deregulated various clock‐controlled metabolic genes involved in insulin signaling and mitochondrial function, for example, Igf1r and Slc2a1. The gene discussed is SLC2A1; the disease is Anxiety.